Page last updated: 2024-08-23

etoposide and vescalagin

etoposide has been researched along with vescalagin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Auzanneau, C; De Giorgi, F; Deffieux, D; Elkaoukabi-Chaibi, A; Ichas, F; Jacquet, R; Montaudon, D; Pourquier, P; Pouységu, L; Puyo, S; Quideau, S	1

Other Studies

1 other study(ies) available for etoposide and vescalagin

Article	Year
The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the α isoform of human DNA topoisomerase II. Molecular pharmacology, 2012, Volume: 82, Issue:1 Topics: Antigens, Neoplasm; Antineoplastic Agents; Catalysis; Cell Proliferation; DNA Breaks, Double-Stranded; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Kinetoplast; Down-Regulation; Etoposide; Humans; Hydrolyzable Tannins; Oxidation-Reduction; Poly-ADP-Ribose Binding Proteins; Protein Isoforms; Tumor Cells, Cultured	2012

Article

Year

The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the α isoform of human DNA topoisomerase II.

Molecular pharmacology, 2012, Volume: 82, Issue:1

Topics: Antigens, Neoplasm; Antineoplastic Agents; Catalysis; Cell Proliferation; DNA Breaks, Double-Stranded; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Kinetoplast; Down-Regulation; Etoposide; Humans; Hydrolyzable Tannins; Oxidation-Reduction; Poly-ADP-Ribose Binding Proteins; Protein Isoforms; Tumor Cells, Cultured

2012